ABT vs MGYR · P/E 25, rev $44.33B vs P/E 9.7, rev $44.8M
Abbott Laboratories (ABT) versus Magyar Bancorp Inc (MGYR) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
Magyar Bancorp Inc (MGYR) is a banks - regional company listed on NASDAQ.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported MGYR revenue for 2026-06-30 was $44.8M. Net income was $9.3M. Revenue was up 51.7% from 2026-03-31 to 2026-06-30. MGYR currently screens at market cap $111.2M and trailing P/E 9.7.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. MGYR currently screens at market cap $111.2M and trailing P/E 9.7.
Not investment advice. Open the ABT and MGYR stock pages for the full models.
Not investment advice.